Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114971 · ClinicalTrials.gov registry record · Phase 4
Labetalol and Esmolol: Vital Signs and Post Operative Pain Management
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT01114971 is a Phase 4 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 75 participants.
The verdict
NCT01114971, a Phase 4 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
This study proposes to investigate the effects of labetalol or esmolol on managing the vital signs (like blood pressure and heart rate) during surgery, on pain management, and on the later recovery after surgery. It will also assess the cost-effectiveness of Labetalol and esmolol for outpatient surgery.
Interventions
- DRUG Labetalol
- DRUG Fentanyl
- DRUG Esmolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2009-09-03 |
| Est. Completion | 2018-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114971
The ClinicalTrials.gov registry entry for NCT01114971 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Labetalol is the first listed.
NCT01114971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01114971 about?
NCT01114971 is a clinical study titled "Labetalol and Esmolol: Vital Signs and Post Operative Pain Management". This study proposes to investigate the effects of labetalol or esmolol on managing the vital signs (like blood pressure and heart rate) during surgery, on pain management, and on the later recovery after surgery. It will also assess the cost-effectiveness of Labetalol and esmolol for outpatient sur...
What is the current status of trial NCT01114971?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2009-09-03. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT01114971?
The interventions under investigation include: Labetalol (DRUG), Fentanyl (DRUG), Esmolol (DRUG).
Who is sponsoring clinical trial NCT01114971?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.